Nobivac Canine 1-DAPPv+L4 (25 Doses)

Nobivac Canine 1-DAPPv+L4 recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus. Additionally, it is an aid in the prevention of disease, urinary shedding and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa.

Protects against all known strains of canine parvovirus (CPV), including CPV-2c^1-2

Contains CPV-2b, one of the most prevalent field strains of parvovirus

High antigenic mass (titer), low passage

Overrides maternal antibodies in your puppies.³

The only leptospirosis vaccine to protect and defend against mortality and urinary shedding

Prevented mortality caused by 4 virulent Leptospira serovars.³

Protects against adenovirus type 1 that causes hepatitis in dogs

Provides disease coverage for commonly spread canine viruses, distemper, adenovirus type 1 (hepatitis), parainfluenza and parvovirus, in 1 formula

Indications

Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1, parainfluenza, and parvovirus

Indicated as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa

Prevents leptospiruria associated with L. grippotyphosa, L. canicila, or L. icterohaemorrhagiae

Aids in the prevention of leptospiruria associated with L. pomona

Recommended for use in healthy dogs 8 weeks of age or older

Shake the Nobivac Lepto4 vial and transfer its contents to the Nobivac Canine 1 DAPPv vial aseptically. Mic gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (1ml) subcutaneously. The initial dose may be given at 8 weeks of age or older. Repeat at 2 to 4 week intervals untul the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recoomended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Subcutaneous or intramuscular injection

Two 1ml doses given 2-4 weeks apart

Repeat at 2-4 week intervals until the dog is 12 weeks of age

Annual revaccination with 1 dose is recommended

SAFETY INFORMATION:

Proven safe across a variety of dog breeds and ages

Now featuring an even higher level of quality due to new VacciPure™ filtration

Please see the product label for safety information.

PRECAUTIONS:

Store at 2°-7°

Do not freeze.

Do not mix with other vaccines.

Use new, non-chemically sterilized needles and syringes.

Burn vaccine container and all unused contents.

WARNINGS:

Contains gentamicin and amphotericin B as preservative.

Vaccinate only health, non-parasitized dogs.

Do not vaccinate pregnant bitches.

The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.